Mini Beam Spatially Fractionated Radiation Therapy (SFRT) is a radiation therapy technique that allows for safe dose escalation for radiation for radiation treatment. Specialized beam collimation creates high-dose peaks organized throughout a target volume with intervening low-dose valleys. Pre-clinical animal studies have shown that with a single dose of Mini Beam SFRT there is much lower toxicity, good tumor control, and employs the patients own immunity to fight the tumor/cancer.
NuVeta will deliver beams 0.5mm thin. This will allow NuVeta to harvest all the benefits of safe Mini Beam SFRT that would be consistent with the previous animal studies and repeat the same results in humans.
Pre-clinical animal studies have shown that with a single dose of RT there is much lower toxicity, good tumor control, and it employs the patient’s own immunity to fight the tumor/cancer. Pre-clinical Mini Beam SFRT data shows the tissue sparing MRT radiation is tumor controlling.
Current attempts to employ Mini Beam SFRT, utilizing traditional radiation machines still experience radiation beams being too broad. Current Mini Beam SFRT radiation beams are too broad/wide at 10-20mm, creating too much damage with a large radiation footprint. NuVeta will deliver beams 0.5mm thin. This will allow NuVeta to fully harvest all the benefits of safe Mini Beam SFRT that would be consistent with the previous animal studies and repeat the same results in humans.